American Bio Medica Corp
OTC:ABMC
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.0001
0.0001
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
American Bio Medica Corp
American Bio Medica Corp. is a biotechnology company. The company is headquartered in Kinderhook, New York. The firm's DOA POCT products offer employers, law enforcement, government, healthcare and education professionals to identify illicit drug use. The firm also provides strip manufacturing and assembly and packaging services for a diagnostic test to an unaffiliated third party that sells this product outside the United States and it manufactures a diagnostic product that is sold under a private label by an unaffiliated third party. Its range of products include Products for the Detection of Drugs in Urine, Rapid Drug Screen, RDS InCup, Rapid TOX, Rapid TOX Cup II, Private Label Products, Products for the Detection of Drugs in Oral Fluid, Products for the Detection of Drugs in Oral Fluid, OralStat and other products.
American Bio Medica Corp. is a biotechnology company. The company is headquartered in Kinderhook, New York. The firm's DOA POCT products offer employers, law enforcement, government, healthcare and education professionals to identify illicit drug use. The firm also provides strip manufacturing and assembly and packaging services for a diagnostic test to an unaffiliated third party that sells this product outside the United States and it manufactures a diagnostic product that is sold under a private label by an unaffiliated third party. Its range of products include Products for the Detection of Drugs in Urine, Rapid Drug Screen, RDS InCup, Rapid TOX, Rapid TOX Cup II, Private Label Products, Products for the Detection of Drugs in Oral Fluid, Products for the Detection of Drugs in Oral Fluid, OralStat and other products.